SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced the appointment of Darrel P. Cohen, M.D., Ph.D. as Chief Medical Officer (CMO), effective immediately. Dr. Cohen…Read More
Viracta Therapeutics Inc Viracta Therapeutics Appoints Darrel P Cohen MD PhD as Chief Medical Officer
